In the prediabetic state of insulin resistance, glycemic control can be achieved using oral agents that either interfere with the absorption of glucose (a-glycosidase and/or pancreatic aamylase inhibitors) or facilitate glucose disposal in peripheral tissues (insulin-sensitizing agents).